期刊文献+

丹参川芎嗪注射液对急性颅脑损伤患者神经功能及炎症因子水平的影响 被引量:2

Effect of Danshen Chuanxiongqin injection on neurological function and inflammatory factors in patients with acute brain injury
下载PDF
导出
摘要 目的探讨丹参川芎嗪注射液对急性颅脑损伤患者神经功能及炎症因子水平的影响。方法选取我院142例急性颅脑损伤患者为研究对象,随机分为对照组和研究组,每组71例。对照组给予常规治疗,研究组在对照组的基础上联合丹参川芎嗪注射液治疗。比较两组患者的临床效果。结果治疗后,两组NIHSS、ADL、MMSE评分、IL-6、IL-8及TNF-α水平较治疗前明显改善,且研究组明显优于对照组(P<0.05)。两组组患者不良反应总发生率比较,差异无统计学意义(P>0.05)。结论丹参川芎嗪注射液可有效促进患者的神经功能、认知功能及生活自理能力,抑制机体炎症反应,且不增加不良反应,值得在急性颅脑损伤治疗中应用推广。 Objective To explore the effect of Danshen Chuanxiongqin injection on neurological function and inflammatory factors in patients with acute brain injury. Methods A total of 142 patients with acute brain injury were selected and randomly divided into control group and study group, with 71 cases in each group. The control group was treated with conventional treatment, and the study group was given Danshen Chuanxiongqin injection based on the control group. The clinical effects were compared between the two groups. Results After treatment, the scores of NIHSS, ADL and MMSE, levels of IL-6, IL-8 and TNF-α improved in the two groups, and those in the study group were better than the control group(P0.05). There was no significant difference in total incidence of adverse reactions between the two groups(P0.05). Conclusion Danshen Chuanxiongqin injection in the treatment of acute brain injury can effectively promote the recovery of neurological function, cognitive function and self-care ability, inhibit the body's inflammatory response, and do not increase adverse reactions, which is worthy of application promotion in patients with acute brain injury.
作者 董宇为 黄喆 冯波 魏小兵 王喆 DONG Yu-wei;HUANG Zhe;FENG Bo;WEI Xiao-bing;WANG Zhe(No.2 Ward of Neurosurgery Department,Hanzhong Central Hospital,Hanzhong 723000,Chin)
出处 《临床医学研究与实践》 2018年第23期23-24,共2页 Clinical Research and Practice
关键词 丹参川芎嗪注射液 急性颅脑损伤 神经功能 炎症因子 Danshen Chuanxiongqin injection acute brain injury neurological function inflammatory factor
  • 相关文献

参考文献8

二级参考文献69

  • 1李增惠,只达石,张赛.颅内压监护在急性中型颅脑损伤患者治疗中的意义[J].中华神经医学杂志,2002,1(1):24-26. 被引量:16
  • 2Erta M, Quintana A, Hidalgo J. Interleukin-6, a major cyto- kine in the central nervous system. Int J Biol Sci, 2012, 8 (9) : 1254-1266.
  • 3Gen6t GF, Johansson PI, Meyer MA, et al. Trauma-induced coagulopathy: standard coagulation tests, biomarkers of eoagu- lopathy, and endothelial damage in patients with traumatic brain injury. J Neurotrauma, 2013, 30(4) : 301-306.
  • 4Papa L, Ramia MM, Kelly JM, et al. Systematic review of clinical research on biomarkers for pediatric traumatic brain in- jury. J Neurotrauma, 2013, 30(5) : 324-338.
  • 5Scheff SW, Ansari MA, Roberts KN. Neuroprotective effect of Pycnogenol following traumatic brain injury. Exp Neurol, 2013, 239: 183-191.
  • 6del Rey A, Apkarian AV, Martina M, et al. Chronic neuro- pathic pain-like behavior and brain-borne IL-115. Ann N Y Acad Sci, 2012, 12(62) : 101-107.
  • 7Lee SH, Kim B J, Kim YB, et al. IL-I induction and IL- 6 suppression are associated with aggravated neuronal damage in a lipopolysaccharide-pretreated kainic acid-induced rat pup seizure model. Neuroimmunomodulation, 2012, 19 ( 5 ) : 319-325.
  • 8Reinsfelt B, Ricksten SE, Zetterberg H, et al. Cerebrospinal fluid markers of brain injury, inflammation, and blood-brain barrier dysfunction in cardiac surgery. Ann Thorac Surg, 2012, 94(2) : 549-555.
  • 9Mifiambres E, Cemborain A, S6nchez-Velasco P, et al. Corre- lation between transcranial interleukin-6 gradient and outcome in patients with acute brain injury. Crit Care Med, 2003, 31 (3) : 933 -938.
  • 10Cope EC, Morris DR, Levenson CW. Improving treatments andoutcomes : an emerging role for zinc in traumatic brain injury [J] .Nutr Rev,2012,70(7) :410-413.

共引文献101

同被引文献27

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部